These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14689351)

  • 1. Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.
    Núñez M; Puoti M; Camino N; Soriano V
    Clin Infect Dis; 2003 Dec; 37(12):1678-85. PubMed ID: 14689351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV and hepatitis B virus: options for managing coinfection.
    Dieterich DT
    Top HIV Med; 2003; 11(1):16-9. PubMed ID: 12717046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.
    Ristig MB; Crippin J; Aberg JA; Powderly WG; Lisker-Melman M; Kessels L; Tebas P
    J Infect Dis; 2002 Dec; 186(12):1844-7. PubMed ID: 12447773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy and HIV/hepatitis B virus coinfection.
    Benhamou Y
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S98-103. PubMed ID: 14986281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatitis B virus infection in patients coinfected with HIV.
    Benhamou Y; Bonyhay L
    Gastroenterol Clin North Am; 2004 Sep; 33(3):617-27, x. PubMed ID: 15324947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy.
    Gaglio PJ; Sterling R; Daniels E; Tedaldi E;
    Clin Infect Dis; 2007 Sep; 45(5):618-23. PubMed ID: 17682998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus.
    Dore GJ; Cooper DA; Pozniak AL; DeJesus E; Zhong L; Miller MD; Lu B; Cheng AK; ;
    J Infect Dis; 2004 Apr; 189(7):1185-92. PubMed ID: 15031786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B in HIV-infected patients.
    Soriano V; Poveda E; Vispo E; Barreiro P
    Clin Liver Dis; 2013 Aug; 17(3):489-501. PubMed ID: 23905818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?].
    Petry W; Erhardt A; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Jan; 38(1):77-87. PubMed ID: 10689749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
    Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
    AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of patients co-infected with hepatitis B virus and HIV.
    Núñez M; Soriano V
    Lancet Infect Dis; 2005 Jun; 5(6):374-82. PubMed ID: 15919623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.
    Núñez M; Pérez-Olmeda M; Díaz B; Ríos P; González-Lahoz J; Soriano V
    AIDS; 2002 Nov; 16(17):2352-4. PubMed ID: 12441815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of chronic hepatitis B in the HIV-infected patient.
    Thio CL
    AIDS Read; 2004 Mar; 14(3):122-9, 133, 136-7. PubMed ID: 15068000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.
    Soriano V; Puoti M; Bonacini M; Brook G; Cargnel A; Rockstroh J; Thio C; Benhamou Y
    AIDS; 2005 Feb; 19(3):221-40. PubMed ID: 15718833
    [No Abstract]   [Full Text] [Related]  

  • 15. [The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too].
    MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866303
    [No Abstract]   [Full Text] [Related]  

  • 16. Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV-HBV-coinfected patients with delayed response to tenofovir.
    Lada O; Gervais A; Branger M; Peytavin G; Roquebert B; Collin G; Fraqueiro G; Moucari R; Leclerc L; Martinot-Peignoux M; Matheron S; Marcellin P
    Antivir Ther; 2012; 17(1):61-70. PubMed ID: 22267470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of chronic hepatitis B in an HIV-positive patient with 3TC-resistant hepatitis B virus.
    Ristig M; Drechsler H; Crippin J; Lisker-Melman M; Tebas P
    AIDS Patient Care STDS; 2003 Sep; 17(9):439-42. PubMed ID: 14588080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
    Benhamou Y
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
    [No Abstract]   [Full Text] [Related]  

  • 19. An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals.
    Nelson M; Portsmouth S; Stebbing J; Atkins M; Barr A; Matthews G; Pillay D; Fisher M; Bower M; Gazzard B
    AIDS; 2003 Jan; 17(1):F7-10. PubMed ID: 12478090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection.
    van Bömmel F; Wünsche T; Mauss S; Reinke P; Bergk A; Schürmann D; Wiedenmann B; Berg T
    Hepatology; 2004 Dec; 40(6):1421-5. PubMed ID: 15565615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.